EGFR and cancer: Taken together, we believe that for targeted therapy of cancer, the expression level of the target antigen, and its status must not be overlooked, and it is time to get back to the target, which in the case anti-EGFR antibodies are the EGFR protein and its dimerisation partners [52,53,54].